al. even speculated that the reduction in thrombocyte and cell adhesive molecules after evolocumab treatment in a mouse model of ischemic stroke was mediated by the inhibition of the ERK/NF-κB pathway [51]. Here, NFKB1 is linked to ischemic stroke.